Henoch S. Hong

Darmstadt, HE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project.

Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 11, 2025

Genomic and Immune Landscape of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Progressing on Anti-PD-1 Treatment.

Genomic and Immune Landscape of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Progressing on Anti-PD-1 Treatment.

Journal: Cancer immunology research

Published: August 07, 2025

Multi-modal image analysis for large-scale cancer tissue studies within IMMUcan.

Multi-modal image analysis for large-scale cancer tissue studies within IMMUcan.

Journal: Cell reports methods

Published: May 27, 2025

Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer.

Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer.

Journal: Journal for immunotherapy of cancer

Published: September 28, 2018

RNA-based adjuvant CV8102 enhances the immunogenicity of a licensed rabies vaccine in a first-in-human trial.

RNA-based adjuvant CV8102 enhances the immunogenicity of a licensed rabies vaccine in a first-in-human trial.

Journal: Vaccine

Published: September 27, 2018

Gene Regulatory Programs Conferring Phenotypic Identities to Human NK Cells.

Gene Regulatory Programs Conferring Phenotypic Identities to Human NK Cells.

Journal: Cell

Published: April 25, 2018

A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer.

A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer.

Journal: Cancer immunology, immunotherapy : CII

Published: July 13, 2017

Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial.

Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial.

Journal: Lancet (London, England)

Published: April 17, 2017

Distinct transcriptional changes in non-small cell lung cancer patients associated with multi-antigenic RNActive® CV9201 immunotherapy.

Distinct transcriptional changes in non-small cell lung cancer patients associated with multi-antigenic RNActive® CV9201 immunotherapy.

Journal: Oncoimmunology

Published: August 22, 2016

Characterization of CD8+ T cell differentiation following SIVΔnef vaccination by transcription factor expression profiling.

Characterization of CD8+ T cell differentiation following SIVΔnef vaccination by transcription factor expression profiling.

Journal: PLoS pathogens

Published: September 18, 2014

High frequencies of polyfunctional CD8+ NK cells in chronic HIV-1 infection are associated with slower disease progression.

High frequencies of polyfunctional CD8+ NK cells in chronic HIV-1 infection are associated with slower disease progression.

Journal: Journal of virology

Published: August 15, 2014

FcγRIII (CD16)-mediated ADCC by NK cells is regulated by monocytes and FcγRII (CD32).

FcγRIII (CD16)-mediated ADCC by NK cells is regulated by monocytes and FcγRII (CD32).

Journal: European journal of immunology

Published: January 29, 2014

Showing 1-12 of 14

Last Updated: 09/26/2026